Pfizer Inc
NYSE:PFE
Balance Sheet
Balance Sheet Decomposition
Pfizer Inc
Current Assets | 43.3B |
Cash & Short-Term Investments | 12.7B |
Receivables | 15.2B |
Other Current Assets | 15.5B |
Non-Current Assets | 183.2B |
Long-Term Investments | 15.4B |
PP&E | 18.9B |
Intangibles | 132.7B |
Other Non-Current Assets | 16.2B |
Current Liabilities | 47.8B |
Accounts Payable | 6.7B |
Accrued Liabilities | 2.8B |
Short-Term Debt | 8.1B |
Other Current Liabilities | 30.2B |
Non-Current Liabilities | 89.7B |
Long-Term Debt | 61.5B |
Other Non-Current Liabilities | 28.2B |
Balance Sheet
Pfizer Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
3 343
|
3 641
|
2 595
|
1 342
|
1 139
|
1 121
|
1 784
|
1 944
|
416
|
2 853
|
|
Cash Equivalents |
3 343
|
3 641
|
2 595
|
1 342
|
1 139
|
1 121
|
1 784
|
1 944
|
416
|
2 853
|
|
Short-Term Investments |
32 779
|
19 649
|
15 255
|
18 650
|
17 694
|
8 525
|
10 437
|
29 125
|
22 316
|
9 837
|
|
Total Receivables |
8 401
|
8 176
|
8 225
|
8 221
|
8 025
|
6 772
|
7 930
|
11 479
|
14 529
|
15 155
|
|
Accounts Receivables |
8 401
|
8 176
|
8 225
|
8 221
|
8 025
|
6 772
|
7 930
|
11 479
|
10 952
|
11 177
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3 577
|
3 978
|
|
Inventory |
5 663
|
7 513
|
6 783
|
7 578
|
7 508
|
7 068
|
8 046
|
9 059
|
8 981
|
10 190
|
|
Other Current Assets |
5 409
|
4 825
|
6 091
|
5 350
|
15 560
|
9 317
|
6 870
|
8 086
|
5 017
|
5 299
|
|
Total Current Assets |
55 595
|
43 804
|
38 949
|
41 141
|
49 926
|
32 803
|
35 067
|
59 693
|
51 259
|
43 334
|
|
PP&E Net |
11 762
|
13 766
|
13 318
|
13 865
|
13 385
|
14 258
|
15 293
|
17 721
|
19 276
|
21 864
|
|
PP&E Gross |
11 762
|
13 766
|
13 318
|
13 865
|
13 385
|
14 258
|
15 293
|
17 721
|
19 276
|
21 864
|
|
Accumulated Depreciation |
13 226
|
13 502
|
14 807
|
16 172
|
16 591
|
14 990
|
14 812
|
15 074
|
15 174
|
16 045
|
|
Intangible Assets |
35 166
|
40 356
|
52 648
|
48 741
|
35 211
|
33 936
|
28 471
|
25 146
|
43 370
|
64 900
|
|
Goodwill |
42 069
|
48 242
|
54 449
|
55 952
|
53 411
|
48 202
|
49 577
|
49 208
|
51 375
|
67 783
|
|
Long-Term Investments |
17 518
|
15 999
|
7 116
|
7 015
|
2 767
|
20 147
|
20 262
|
21 526
|
15 069
|
15 368
|
|
Other Long-Term Assets |
5 456
|
5 214
|
5 135
|
5 083
|
4 722
|
18 248
|
5 559
|
8 182
|
16 856
|
13 253
|
|
Other Assets |
42 069
|
48 242
|
54 449
|
55 952
|
53 411
|
48 202
|
49 577
|
49 208
|
51 375
|
67 783
|
|
Total Assets |
167 566
N/A
|
167 381
0%
|
171 615
+3%
|
171 797
+0%
|
159 422
-7%
|
167 594
+5%
|
154 229
-8%
|
181 476
+18%
|
197 205
+9%
|
226 502
+15%
|
|
Liabilities | |||||||||||
Accounts Payable |
3 210
|
3 620
|
4 536
|
4 656
|
4 674
|
3 887
|
4 309
|
5 578
|
6 809
|
6 710
|
|
Accrued Liabilities |
1 841
|
2 359
|
2 487
|
2 196
|
2 397
|
2 659
|
3 379
|
3 781
|
4 027
|
3 303
|
|
Short-Term Debt |
2 130
|
6 440
|
6 463
|
6 407
|
4 055
|
14 733
|
701
|
605
|
395
|
8 096
|
|
Current Portion of Long-Term Debt |
3 011
|
3 719
|
4 225
|
3 546
|
4 776
|
1 462
|
2 002
|
1 636
|
2 550
|
2 254
|
|
Other Current Liabilities |
11 395
|
13 261
|
13 404
|
13 622
|
15 956
|
14 563
|
15 529
|
31 071
|
28 357
|
27 431
|
|
Total Current Liabilities |
21 587
|
29 399
|
31 115
|
30 427
|
31 858
|
37 304
|
25 920
|
42 671
|
42 138
|
47 794
|
|
Long-Term Debt |
31 541
|
28 740
|
31 398
|
33 538
|
32 909
|
35 955
|
37 133
|
36 195
|
32 884
|
61 538
|
|
Deferred Income Tax |
23 317
|
26 877
|
30 753
|
3 900
|
3 700
|
5 652
|
4 063
|
349
|
1 023
|
640
|
|
Minority Interest |
321
|
278
|
296
|
348
|
351
|
303
|
235
|
262
|
256
|
274
|
|
Other Liabilities |
19 499
|
17 367
|
18 509
|
32 276
|
27 197
|
25 236
|
23 640
|
24 799
|
25 244
|
27 241
|
|
Total Liabilities |
96 265
N/A
|
102 661
+7%
|
112 071
+9%
|
100 489
-10%
|
96 015
-4%
|
104 450
+9%
|
90 991
-13%
|
104 276
+15%
|
101 545
-3%
|
137 487
+35%
|
|
Equity | |||||||||||
Common Stock |
484
|
485
|
485
|
485
|
486
|
485
|
470
|
473
|
476
|
478
|
|
Retained Earnings |
72 176
|
71 993
|
71 774
|
85 291
|
89 554
|
97 670
|
96 770
|
103 394
|
125 656
|
118 353
|
|
Additional Paid In Capital |
78 977
|
81 016
|
82 685
|
84 278
|
86 253
|
87 428
|
88 674
|
90 591
|
91 802
|
92 631
|
|
Unrealized Security Profit/Loss |
222
|
227
|
131
|
401
|
68
|
35
|
116
|
220
|
220
|
9
|
|
Treasury Stock |
73 021
|
79 252
|
84 364
|
89 425
|
101 610
|
110 801
|
110 988
|
111 361
|
113 969
|
114 487
|
|
Other Equity |
7 093
|
9 295
|
10 905
|
9 722
|
11 208
|
11 603
|
11 804
|
5 677
|
8 525
|
7 952
|
|
Total Equity |
71 301
N/A
|
64 720
-9%
|
59 544
-8%
|
71 308
+20%
|
63 407
-11%
|
63 144
0%
|
63 238
+0%
|
77 200
+22%
|
95 660
+24%
|
89 014
-7%
|
|
Total Liabilities & Equity |
167 566
N/A
|
167 381
0%
|
171 615
+3%
|
171 797
+0%
|
159 422
-7%
|
167 594
+5%
|
154 229
-8%
|
181 476
+18%
|
197 205
+9%
|
226 501
+15%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
6 291
|
6 175
|
6 070
|
5 979
|
5 717
|
5 534
|
5 567
|
5 620
|
5 616
|
5 646
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|